Healthcare -
Biotechnology - NASDAQ - US
$ 54.4243
4.44 %
$ 3.37 B
Market Cap
69.0
P/E
PTGX - CASH FROM OPERATIONS
Cash from Operations PTGX - Protagonist Therapeutics, Inc.
184 M
LAST VALUE
92.43%
2 YEAR CAGR
45.11%
5 YEAR CAGR
38.40%
10 YEAR CAGR